• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE Back to Search Results
Model Number 2115
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Pseudoaneurysm (2605)
Event Date 02/28/2023
Event Type  Injury  
Manufacturer Narrative
(b)(4).An investigation has been opened to review historical data and risk documentation.A follow up report will be submitted after investigation.
 
Event Description
It was reported that: pt developed a pseudo aneurysm that night.Needed a blood transfusion and went to surgery.Pt recovered and was discharged home.This is from a phone call from the tavr coordinator.Additional information on 10mar2023: during a tavr procedure on (b)(6) 2023 micropunture and ultrasound were utilized to gain access in the right common femoral artery.Vessel size was 7.2mm with no reported calcification or tortuosity.Measured depth for the manta was 5+1=6 and there were no issues advancing or withdrawing procedural sheaths.Blood pressure was 158/65mmhg and act was 360 prior to closure.50mg of protamine and an unknown dose of heparin were administered intravenously during the procedure.The account stated that the patient was taken to surgery later that night for bleeding and had a blood transfusion.The account stated that the patient had a pseudoaneurysm.The account also noted that the physician had stuck through the inguinal ligament during access which led to the complication.Also , the account stated that they would not provide any more information regarding the case.The patient was reported as fine post the procedure and was discharged home.
 
Manufacturer Narrative
(b)(4).The device was not returned for investigation.No return product evaluation could be completed.Ct images were obtained by vsi however, were inconclusive and did not provide any information relevant to the analysis.The device lot history record review indicated no non-conformities related to this lot, therefore, supporting the device met material, assembly, and performance specifications prior to shipment.Based on the information submitted, following a tavr procedure, an 18f manta was deployed for closure in the right common femoral artery.Access was achieved utilizing micropuncture and ultrasound.Access position was unable to be determined due to no angiograms being taken during the procedure.Although, during access, the physician had stuck through the inguinal ligament.Arteriotomy was 7.2mm, with no calcification or tortuosity, with a measured depth of 5mm + 1mm.No issues were encountered advancing or withdrawing the procedural sheaths.Prior to closure, activated clotting time (act) was 360, and heparin and protamine were administered.The manta device was deployed to the measured depth, and hemostasis was achieved after five minutes of manual pressure.Later that evening, the patient was bleeding, developed a pseudo aneurysm, was transferred to surgery, and received an unknown amount of packed red blood cells.A pseudo-aneurysm can go undetected and not cause any complications and can occur because of surgery or trauma; the formation of a pseudoaneurysm does not signify a device failure.The suspected root cause of the pseudo aneurysm may likely be due to user error in utilizing manta in a patient with high access (at or above the inguinal ligament).Due to the location of the manta deployment, it is likely the implant was unable to effectively maintain a seal and the implant became dislodged.The patient recovered and was later discharged home.The ifu warns do not to use if the puncture site is proximal to the inguinal ligament or above the most inferior border of the epigastric artery (iea), as this may result in retroperitoneal bleeding.The following potential adverse events related to the deployment of vascular closure devices include retroperitoneal bleeding, and its consequences, as a result of failed closure in the setting of access above the inguinal ligament or the most inferior border of the epigastric artery (iea).Additionally, procedure requirements listed in the ifu indicate a pre-procedure cta is recommended to assess femoral artery anatomy.
 
Event Description
It was reported that: pt developed a pseudo aneurysm that night.Needed a blood transfusion and went to surgery.Pt recovered and was discharged home.This is from a phone call from the tavr coordinator.Additional information on 10mar2023: during a tavr procedure on (b)(6) 2023 micropunture and ultrasound were utilized to gain access in the right common femoral artery.Vessel size was 7.2mm with no reported calcification or tortuosity.Measured depth for the manta was 5+1=6 and there were no issues advancing or withdrawing procedural sheaths.Blood pressure was 158/65mmhg and act was 360 prior to closure.50mg of protamine and an unknown dose of heparin were administered intravenously during the procedure.The account stated that the patient was taken to surgery later that night for bleeding and had a blood transfusion.The account stated that the patient had a pseudoaneurysm.The account also noted that the physician had stuck through the inguinal ligament during access which led to the complication.Also , the account stated that they would not provide any more information regarding the case.The patient was reported as fine post the procedure and was discharged home.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MANTA 18F
Type of Device
VASCULAR CLOSURE DEVICE
Manufacturer (Section D)
ESSENTIAL MEDICAL, INC.
exton
Manufacturer (Section G)
ESSENTIAL MEDICAL, INC.
260 sierra drive
exton
Manufacturer Contact
elaine cully
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key16536567
MDR Text Key311217456
Report Number3010252479-2023-00052
Device Sequence Number1
Product Code MGB
UDI-Device Identifier00856279007062
UDI-Public00856279007062
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/15/2023
Device Model Number2115
Device Catalogue Number2115
Device Lot NumberMN2201468
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexFemale
-
-